Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIMEAxel Bex, John Haanen, Peter F.A. Mulders et al.|European Urology Supplements|2018Cited by 7
Podium Session 1: Prostate Cancer June 26, 2016 1050–1150D. Robert Siemens, Ronald Kodama, Arnauld Villers et al.|Europe PMC (PubMed Central)|2016Cited by 0